Lataa...

Endostatin and Oxaliplatin‐Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study

LESSONS LEARNED. Definitive concurrent chemoradiotherapy based on oxaliplatin and endostatin was effective with the objective response rate exceeding 80%, and the treatment‐related toxicities were acceptable. The treatment compliance of the current combination was much higher, without significant re...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncologist
Päätekijät: Li, Wenxin, Chen, Peng, Zhang, Ni, Song, Tao, Wu, Shixiu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Inc. 2019
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6459259/
https://ncbi.nlm.nih.gov/pubmed/30850562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0119
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!